Expression of p53,Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease

被引:0
|
作者
Anatol Panasiuk
Janusz Dzieciol
Bozena Panasiuk
Danuta Prokopowicz
机构
[1] Department of Human Anatomy Medical University of Bialystok Poland
[2] Department of Infectious Diseases Medical University of Biaystok Poland
[3] Department of Infectious Diseases Medical University of Biaystok Poland
关键词
Apoptosis; Non-alcoholic liver disease; p53; Bcl-2; Bax; Immunohistochemistry;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
AIM: To analyze the protein expression essential for apoptosis in liver steatosis. METHODS: The expression of proapoptotic proteins p53, Bax, and antiapoptotic Bcl-2 in hepatocytes with steatosis (SH) and without steatosis (NSH) was evaluated in 84 patients at various stages of non-alcoholic fatty liver disease (NAFLD). RESULTS: Immunohistochemical staining of liver tissue showed the activation of p53 protein in SH and NSH with increased liver steatosis, diminished Bcl-2 and slightly decreased Bax protein. Positive correlation was found between the stage of liver steatosis with p53 expression in SH (r = 0.54, P < 0.01) and NSH (r = 0.49, P < 0.01). The antiapoptotic protein Bcl-2 was diminished together with the advancement of liver steatosis, especially in non-steatosed hepatocytes (r =0.43, P < 001). CONCLUSION: Apoptosis is one of the most important mechanisms leading to hepatocyte elimination in NAFLD. The intensification of inflammation in NAFLD induces proapoptotic protein p53 with the inhibition of antiapoptotic Bcl-2.
引用
收藏
页码:6198 / 6202
页数:5
相关论文
共 50 条
  • [1] Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease
    Panasiuk, Anatol
    Dzieciol, Janusz
    Panasiuk, Bozena
    Prokopowicz, Danuta
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (38) : 6198 - 6202
  • [2] Bax, Bcl-2, and p53 expression in endometrial cancer
    Sakuragi, N
    Salah-eldin, A
    Watari, H
    Itoh, T
    Inoue, S
    Moriuchi, T
    Fujimoto, S
    GYNECOLOGIC ONCOLOGY, 2002, 86 (03) : 288 - 296
  • [3] Expression of Bcl-2, Bax and p53 proteins in pituitary adenomas an immunohistochemical study
    Ozer, E
    Canda, MS
    Ulukus, C
    Guray, M
    Erbayraktar, S
    TUMORI, 2003, 89 (01) : 54 - 59
  • [4] Expression of apoptosis regulatory proteins p53, bcl-2 and bax in recurrent aphthous ulceration
    Ribeiro, D.
    Rodrigues, J. F.
    Oshima, C.
    Ihara, S.
    Franco, M.
    VIRCHOWS ARCHIV, 2011, 459 : S116 - S116
  • [5] p53, bcl-2, and Bax expression in renal cell carcinoma
    Vasavada, SP
    Novick, AC
    Williams, BRG
    UROLOGY, 1998, 51 (06) : 1057 - 1061
  • [6] Expression of apoptosis regulatory proteins p53, bcl-2 and bax in recurrent aphthous ulceration
    Pinto Rodrigues, J. F. N.
    Fujiyama Oshima, C. T.
    Ribeiro Paiotti, A. P.
    Franco, M.
    Miki Ihara, S. S.
    Ribeiro, D. A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (10) : 1247 - 1251
  • [7] Expression of Bax, Bcl-2, and p53 in progressive multifocal leukoencephalopathy
    Yang, B
    Prayson, RA
    MODERN PATHOLOGY, 2000, 13 (10) : 1115 - 1120
  • [8] Expression of Bcl-2, Bax, and p53 proteins in carcinogenesis of squamous cell lung cancer
    Chen, Y
    Sato, M
    Fujimura, S
    Endo, C
    Sakurada, A
    Aikawa, H
    Takahashi, H
    Tanita, T
    Kondo, T
    Saito, Y
    Sagawa, M
    ANTICANCER RESEARCH, 1999, 19 (2B) : 1351 - 1355
  • [9] Immunohistochemical expression of Bcl-2, Bcl-xL, Bax, p53 proteins in gastric adenoma and adenocarcinoma
    Lee, D
    Han, S
    Baek, J
    Ahn, B
    Lee, E
    Chung, I
    Park, D
    GASTROENTEROLOGY, 2003, 124 (04) : A186 - A186
  • [10] Expression of p53 and bcl-2 proteins in laryngeal cancer
    Gryczynski, M
    Kobos, J
    Pietruszewska, W
    4TH EUROPEAN CONGRESS OF OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, VOLS 1 AND 2, 2000, : 731 - 735